Patent details

EP3601569 Title: MODULATORS OF PCSK9 EXPRESSION

Basic Information

Publication number:
EP3601569
PCT Application Number:
US2018023936
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187723044
PCT Publication Number:
WO2018175839
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MODULATORS OF PCSK9 EXPRESSION
French Title of Invention:
MODULATEURS DE L'EXPRESSION DE PCSK9
German Title of Invention:
MODULATOREN DER PCSK9-EXPRESSION
SPC Number:

Dates

Filing date:
23/03/2018
Grant date:
27/09/2023
EP Publication Date:
05/02/2020
PCT Publication Date:
27/09/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/09/2023
EP B1 Publication Date:
27/09/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
23/03/2024
Expiration date:
23/03/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/09/2023
 
 

Name:
Ionis Pharmaceuticals, Inc.
Address:
2855 Gazelle Court, Carlsbad, CA 92010, United States (US)

Inventor

1

Name:
SWAYZE, Eric, E.
Address:
United States (US)

2

Name:
FREIER, Susan, M.
Address:
United States (US)

3

Name:
BUI, Huynh-Hoa
Address:
United States (US)

Priority

Priority Number:
201762476051 P
Priority Date:
24/03/2017
Priority Country:
United States (US)

Classification

IPC classification:
C12N 15/113; A61K 31/712; A61K 31/7125; A61P 3/06;

Publication

European Patent Bulletin

1

Issue number:
202339
Publication date:
27/09/2023
Description:
Grant (B1)

2

Issue number:
202344
Publication date:
01/11/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages